Your browser doesn't support javascript.
loading
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon.
Spillane, Cathy D; Cooke, Niamh M; Ward, Mark P; Kenny, Dermot; Blackshields, Gordon; Kelly, Tanya; Bates, Mark; Huang, Yanmei; Martin, Cara; Skehan, Sinead; Canney, Aoife; Gallagher, Michael; Smyth, Paul; Brady, Nathan; Clarke, Andres; Mohamed, Bashir; Norris, Lucy; Brooks, Doug A; Brooks, Robert D; Heatlie, Jessica K; Selemidis, Stavros; Hanniffy, Sean; Dixon, Eric; Sheils, Orla; O'Toole, Sharon A; O'Leary, John J.
Afiliação
  • Spillane CD; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Irel
  • Cooke NM; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin, Ireland.
  • Ward MP; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Kenny D; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin, Ireland.
  • Blackshields G; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland.
  • Kelly T; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Bates M; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Huang Y; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland; School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan,
  • Martin C; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Skehan S; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Canney A; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Gallagher M; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Smyth P; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland.
  • Brady N; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Clarke A; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Mohamed B; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Norris L; Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.
  • Brooks DA; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Cancer Research Institute, University of South Australia, Adelaide 5001, Australia.
  • Brooks RD; Cancer Research Institute, University of South Australia, Adelaide 5001, Australia.
  • Heatlie JK; Cancer Research Institute, University of South Australia, Adelaide 5001, Australia.
  • Selemidis S; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia.
  • Hanniffy S; BD Research Centre Ireland, Limerick, Ireland.
  • Dixon E; BD Technologies and Innovation, Research Triangle Park, NC, USA.
  • Sheils O; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland.
  • O'Toole SA; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland; Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity
  • O'Leary JJ; Department of Histopathology, Trinity College Dublin and Trinity St James's Cancer Institute, Dublin, Ireland; Emer Casey Molecular Pathology Research Laboratory, Coombe Women and Infants University Hospital, Dublin, Ireland; The Biomedical Diagnostics Institute, Dublin City University, Dublin, Irel
Transl Oncol ; 14(12): 101229, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34592589
ABSTRACT
Tumour metastasis accounts for over 90% of cancer related deaths. The platelet is a key blood component, which facilitates efficient metastasis. This study aimed to understand the molecular mechanisms involved in tumour-platelet cell interactions. The interaction between cancer cells and platelets was examined in 15 epithelial cell lines, representing 7 cancer types. Gene expression analysis of EMT-associated and cancer stemness genes was performed by RT-PCR. Whole transcriptome analysis (WTA) was performed using Affymetrix 2.0ST arrays on a platelet co-cultured ovarian model. Platelet adhesion and activation occurred across all tumour types. WTA identified increases in cellular movement, migration, invasion, adhesion, development, differentiation and inflammation genes and decreases in processes associated with cell death and survival following platelet interaction. Increased invasive capacity was also observed in a subset of cell lines. A cross-comparison with a platelet co-cultured mouse model identified 5 common altered genes; PAI-1, PLEK2, CD73, TNC, and SDPR. Platelet cancer cell interactions are a key factor in driving the pro-metastatic phenotype and appear to be mediated by 5 key genes which have established roles in metastasis. Targeting these metastasis mediators could improve cancer patient outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article